documents

Regulatory documents from Regulations.gov including rules, proposed rules, notices, and supporting materials.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

7 rows where docket_id = "FDA-2022-E-2185" sorted by posted_date descending

✎ View and edit SQL

This data as json, CSV (advanced)

Suggested facets: title, subtype, posted_date, posted_month, comment_start_date, posted_date (date), comment_start_date (date), comment_end_date (date), last_modified (date)

posted_year 4

document_type 2

agency_id 1

id agency_id docket_id title document_type subtype posted_date ▲ posted_year posted_month comment_start_date comment_end_date last_modified fr_doc_num open_for_comment withdrawn object_id
FDA-2022-E-2185-0007 FDA None FDA-2022-E-2185 Letter from FDA CDER to U. S. Patent and Trademark Office Other Letter(s) 2025-01-13T05:00:00Z 2025 1 2025-01-13T05:00:00Z   2025-01-13T20:08:29Z   0 0 09000064868b7e65
FDA-2022-E-2185-0006 FDA None FDA-2022-E-2185 Letter from FDA CDER to U.S. Patent and Trademark Office Other Letter(s) 2024-01-18T05:00:00Z 2024 1 2024-01-18T05:00:00Z   2025-01-13T19:51:37Z   0 0 09000064863a977a
FDA-2022-E-2185-0005 FDA None FDA-2022-E-2185 Letter from U.S. Patent and Trademark Office to FDA CDER Other Letter(s) 2024-01-11T05:00:00Z 2024 1 2024-01-11T05:00:00Z   2024-01-11T20:55:22Z   0 0 090000648638a3c3
FDA-2022-E-2185-0004 FDA None FDA-2022-E-2185 Determination of Regulatory Review Period for Purposes of Patent Extension; Nextstellis Notice Determinations 2023-12-08T05:00:00Z 2023 12 2023-12-08T05:00:00Z 2024-02-07T04:59:59Z 2023-12-08T14:56:17Z 2023-26988 0 0 090000648631666f
FDA-2022-E-2185-0003 FDA None FDA-2022-E-2185 Letter from FDA CDER to U. S. Patent and Trademark Office Other Letter(s) 2022-09-21T04:00:00Z 2022 9 2022-09-21T04:00:00Z   2022-09-21T19:30:55Z   0 0 09000064853481dd
FDA-2022-E-2185-0002 FDA None FDA-2022-E-2185 Patent Term Extension Application for NEXTSTELLIS ® (drospirenone and estetrol tablets).U.S. Patent No. 7,732,43 Other Application 2022-09-09T04:00:00Z 2022 9 2022-09-09T04:00:00Z   2023-06-20T17:27:52Z   0 0 09000064852dc87b
FDA-2022-E-2185-0001 FDA None FDA-2022-E-2185 Letter from U S Patent and Trademark Office Other Letter(s) 2022-09-09T04:00:00Z 2022 9 2022-09-09T04:00:00Z   2023-06-20T17:29:46Z   0 0 09000064852dc5ff

Advanced export

JSON shape: default, array, newline-delimited, object

CSV options: 

CREATE TABLE documents (
    id TEXT PRIMARY KEY,
    agency_id TEXT,
    docket_id TEXT REFERENCES dockets(id),
    title TEXT,
    document_type TEXT,
    subtype TEXT,
    posted_date TEXT,
    posted_year INTEGER,
    posted_month INTEGER,
    comment_start_date TEXT,
    comment_end_date TEXT,
    last_modified TEXT,
    fr_doc_num TEXT,
    open_for_comment INTEGER,
    withdrawn INTEGER,
    object_id TEXT
);
CREATE INDEX idx_docs_agency ON documents(agency_id);
CREATE INDEX idx_docs_docket ON documents(docket_id);
CREATE INDEX idx_docs_date ON documents(posted_date);
CREATE INDEX idx_docs_year ON documents(posted_year);
CREATE INDEX idx_docs_type ON documents(document_type);
CREATE INDEX idx_docs_frnum ON documents(fr_doc_num);
CREATE INDEX idx_docs_comment_end ON documents(comment_end_date) WHERE comment_end_date IS NOT NULL AND withdrawn = 0;